ポリ硫黄型新規抗がん剤の開発とシステイン制限による効果増強作用

• Project/Area Number: 25K22315
• Research Category: Grant-in-Aid for Challenging Research (Exploratory)
• Allocation Type: Multi-year Fund
• Review Section: Medium-sized Section 37:Biomolecular chemistry and related fields
• Research Institution: Kumamoto University
• Principal Investigator: 澤 智裕 熊本大学, 大学院生命科学研究部(医), 教授 (30284756)
• Project Period (FY): 2025-06-27 – 2027-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000); Fiscal Year 2026: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000); Fiscal Year 2025: ¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)